PTSD Trial, Recruiting (NCT06193161)

PTSD Trial, Recruiting NCT06193161 Sponsor: Karolinska Institutet Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06193161 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a current main (primary) diagnosis of PTSD, confirmed using the standard DSM-5 diagnostic guidelines
People who are 18 years of age or older
People who are able to read and write in English
People who are immigrants currently living in Sweden
People who are able to give their consent to participate digitally (online)
People who have access to a computer or internet-connected device every day

Who may not be able to join:

People for whom PTSD is not the main concern being treated
People who have started taking or changed the dose of any psychiatric medication within the 4 weeks before the trial treatment would begin
People who are experiencing serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders, or who are currently at a level of suicide risk that requires immediate clinical attention
People who are currently receiving trauma-focused cognitive behavioural therapy (a specific type of talking therapy for trauma) or Eye Movement Desensitisation and Reprocessing (EMDR) therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Bragesjö, PhD, Karolinska Institutet

Phone: +46703399387

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06193161

Sponsor: Karolinska Institutet

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: +46703399387

More information: https://clinicaltrials.gov/study/NCT06193161

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a current main (primary) diagnosis of PTSD, confirmed using the standard DSM-5 diagnostic guidelines
People who are 18 years of age or older
People who are able to read and write in English
People who are immigrants currently living in Sweden
People who are able to give their consent to participate digitally (online)
People who have access to a computer or internet-connected device every day

Who may not be able to join:

People for whom PTSD is not the main concern being treated
People who have started taking or changed the dose of any psychiatric medication within the 4 weeks before the trial treatment would begin
People who are experiencing serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders, or who are currently at a level of suicide risk that requires immediate clinical attention
People who are currently receiving trauma-focused cognitive behavioural therapy (a specific type of talking therapy for trauma) or Eye Movement Desensitisation and Reprocessing (EMDR) therapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Karolinska Institutet

Registry

ClinicalTrials.gov

Start date

15 March 2024

Est. completion

15 October 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Change in PTSD symptoms as assessed by the PTSD Check List - DSM-5 (PCL-5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov